Abstract: A graphene electrode, an energy storage device employing the same, and a method for fabricating the same are provided. The graphene electrode includes a metal foil, a non-doped graphene layer, and a hetero-atom doped graphene layer. Particularly, the hetero-atom doped graphene layer is separated from the metal foil by the non-doped graphene layer.

Abstract: Disclosed is an intralymphatic delivery method for treating lymphatic cancer using hyaluronan nanoparticles. These nanoparticles include a hyaluronic acid derivative and a platinum compound. The hyaluronan derivative includes hyaluronic acid, modified histidine and optionally one or more of a polymer or a C4-C20 alkyl. The hyaluronic acid derivative may include linking group(s) that connect the polymer or the C4-C20 alkyl to the hyaluronic acid. The platinum compound includes dichloro(1,2-diaminocyclohexane) platinum (DACHPt), cisplatin and oxaliplatin. This intralymphatic delivery method offers significant advantages for the use of platinum medicines in treating lymphatic cancer.

Abstract: The disclosure provides a biomedical composition, including: a hyaluronic acid; a modified histidine; and a polymer or C4-C20 alkane, wherein the modified histidine and the polymer or C4-C20 alkane are grafted to at least one primary hydroxyl group of the hyaluronic acid to allow the hyaluronic acid to form a hyaluronic acid derivative, wherein a graft ratio of the modified histidine is about 1-100%, and a graft ratio of the polymer or C4-C20 alkane is about 0-40%.

Abstract: A light detection apparatus and an image reconstruction method using the light detection apparatus are provided. The light detection apparatus includes a detection module and a control module. The detection module has a plurality of light detection units to constitute a hexagonal or honeycomb array structure. Each of the light detection units has a light-emitting element and a photosensitive element. The control module has a selector and a multiplexer. The selector selects at least one light-emitting element to produce a light source, so as to emit a plurality of photons to an object-under-test. The multiplexer selects at least one photosensitive element to detect light signals of the photons diffused to the object-under-test. The invention can obtain more light signals from the object-under-test to reconstruct images of the object-under-test.

Abstract: Provided is a coating composition having anti-fogging and heat-insulating functions, which includes a mesoporous material, an organic polysiloxane, and co-doped tungsten oxide as shown in formula (I), MxWO3-yAy wherein M is an alkali metal element, W is tungsten, O is oxygen, A is halogen, 0<x?1, and 0<y?0.5. Further provided are a method for preparing a coating composition having anti-fogging and heat-insulating functions and a film formed from the coating composition.

Abstract: Provided is a coating composition having anti-fogging and heat-insulating functions, which includes a mesoporous material, an organic polysiloxane, and co-doped tungsten oxide as shown in formula (I), MxWO3-yAy wherein M is an alkali metal element, W is tungsten, O is oxygen, A is halogen, 0<x?1, and 0<y?0.5. Further provided are a method for preparing a coating composition having anti-fogging and heat-insulating functions and a film formed from the coating composition.

Abstract: An illumination device including a base, at least one LED light source and a diffusing element is provided. The base has a supporting plane. The LED light source disposed on the supporting plane has a light emitting surface substantially parallel to the supporting plane. The diffusing element disposed on the supporting plane to cover the at least one LED light source. The diffusing element includes a first portion and a second portion. The first portion located above the at least one LED light source. The second portion connected between the first portion and the base. An optical characteristic of the first portion is different from that of the second portion so that a non-continuous boundary is defined between the first portion and the second portion.

Abstract: A method, an electronic device, and a user interface for on-demand detecting a malware are provided and adapted for estimating whether an application has vulnerabilities or malicious behaviors. The method includes the following steps. Firstly, evaluating a risk level and a test time of the application which has vulnerabilities or malicious behaviors. Next, detecting the application by selection of user to estimate the risk level of the application which has vulnerabilities or malicious behaviors and then correspondingly generating a detection result. Therefore, the method, the electronic device, and the user interface for on-demand detecting the malware can detect the risk level of the application which has vulnerabilities or malicious behaviors before getting virus pattern of the variant or new malware.

Abstract: The invention provides a meat-fat substitute, the forming composition thereof including: at least one edible gum; at least one starch; and water, wherein the at least one edible gum is present in an amount of about 0.5-20 parts by weight, the at least one starch is present in an amount of about 0.5-10 parts by weight and the water is present in an amount of about 60-99 parts by weight.

Abstract: The disclosure provides a pharmaceutical composition for inhibiting angiogenesis, including an effective amount of a lignan as an effective ingredient. The pharmaceutical composition may further include a pharmaceutically acceptable carrier or salt. The disclosure also provides a method for inhibiting angiogenesis, including administering an effective amount of a lignan as an effective ingredient for inhibiting angiogenesis to a subject in need thereof.

Abstract: A method, an electronic device, and a user interface for on-demand detecting a malware are provided and adapted for estimating whether an application has vulnerabilities or malicious behaviors. The method includes the following steps. Firstly, evaluating a risk level and a test time of the application which has vulnerabilities or malicious behaviors. Next, detecting the application by selection of user to estimate the risk level of the application which has vulnerabilities or malicious behaviors and then correspondingly generating a detection result. Therefore, the method, the electronic device, and the user interface for on-demand detecting the malware can detect the risk level of the application which has vulnerabilities or malicious behaviors before getting virus pattern of the variant or new malware.

Abstract: The present invention discloses a content protection system in a storage medium and the method of the same. The storage medium includes a flash disk, a memory card, a hard disk, a CDR, or a MO. In one aspect of the present invention, the content protection system in a storage medium includes a database; a partitioning module coupled to the database to partition the storage medium; and a link table managing module coupled to the database to establish and manage a link table of a file to be stored in the storage medium.

Abstract: An isolated human liver tumor cell line is provided and is named as ITRI-H16, and which was deposited in the Food Industry Research and Development Institute with the accession number BCRC960432 on Nov. 7, 2011. A method of an agent screening is also provided. The method includes providing the isolated human liver tumor cell line ITRI-H16 and treating an interest compound to the ITRI-H16 cell line to determine an effect of the interesting compound on the ITRI-H16 cell line.

Abstract: An isolated human liver tumor cell line is provided, which was named as ITRI-H28 and deposited in the Food Industry Research and Development Institute with the accession number BCRC960457 on Dec. 14, 2012. A method of an agent screening is also provided. The method includes providing the isolated human liver tumor cell line ITRI-H28 and adding an interest compound into the ITRI-H28 cell line to determine an effect on the ITRI-H28 cell line.

Abstract: An illumination device including a base, at least one LED light source and a first diffusing element is provided. The base has a supporting plane. The LED light source disposed on the supporting plane has a light emitting surface substantially parallel to the supporting plane. The first diffusing element disposed on the supporting plane is a hollow column surrounding the LED light source. An inner diameter width of the first diffusing element is gradually reduced outward from the base. The first diffusing element has a rough surface comprising a plurality of surface structures.

Abstract: The disclosure provides a biomedical composition, including: a hyaluronic acid; a modified histidine; and a polymer or C4-C20 alkane, wherein the modified histidine and the polymer or C4-C20 alkane are grafted to at least one primary hydroxyl group of the hyaluronic acid to allow the hyaluronic acid to form a hyaluronic acid derivative, wherein a graft ratio of the modified histidine is about 1-100%, and a graft ratio of the polymer or C4-C20 alkane is about 0-40%.

Abstract: An illumination device including a base, at least one LED light source and a diffusing element is provided. The base has a supporting plane. The LED light source disposed on the supporting plane has a light emitting surface substantially parallel to the supporting plane. The diffusing element disposed on the supporting plane to cover the at least one LED light source. The diffusing element includes a first portion and a second portion. The first portion located above the at least one LED light source. The second portion connected between the first portion and the base. An optical characteristic of the first portion is different from that of the second portion so that a non-continuous boundary is defined between the first portion and the second portion.

Abstract: The disclosure provides a pharmaceutical composition for inhibiting angiogenesis, including an effective amount of an extract of Juniperus chinensis or an effective amount of a lignan as an effective ingredient. The pharmaceutical composition may further include a pharmaceutically acceptable carrier or salt. The disclosure also provides a method for inhibiting angiogenesis, including administering an effective amount of an extract of Juniperus chinensis or an effective amount of a lignan as an effective ingredient for inhibiting angiogenesis to a subject in need thereof.

Abstract: A coating includes an organosiloxane polymer and a mesoporous silica material bonded with the organosiloxane polymer. A monomer of the organosiloxane polymer is and the surface of the mesoporous silica material includes a hydrophilic group. A method for manufacturing the coating includes the following steps. Provide an organosiloxane polymer polymerized from a plurality of organosiloxanes including a terminal functional group. Provide a mesoporous silica precursor including a surface functional group. The organosiloxane polymer and the mesoporous silica precursor are blended in a solution, so that the surface functional group reacts with the terminal functional group to form a bond, and a mesoporous silica material is formed, as well as the surface of the mesoporous silica material includes a hydrophilic group. A film including a thickness of 0.1-500 ?m is formed by the coating.

Abstract: The disclosure provides a graphene electrode, an energy storage device employing the same, and a method for fabricating the same. The graphene electrode includes a metal foil, a non-doped graphene layer, and a hetero-atom doped graphene layer. Particularly, the hetero-atom doped graphene layer is separated from the metal foil by the non-doped graphene layer.